http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d275c857236f935c7c6f810040faf39c
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Gonda |
| name | Xenia Gonda |
| given-name | Xenia |
| organization-name | Department of Psychiatry and Psychotherapy, Semmelweis University, Gyulai Pál utca 2., H-1085 Budapest, Hungary Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest. NAP-2-SE New Antidepressant Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest. NAP3.0-SE Neuropsychopharmacology Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary Department of Pharmacodynamics, Semmelweis University, 1089, Budapest, Hungary;; MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, 1089, Budapest, Hungary;; Department of Clinical and Theoretical Mental Health, Semmelweis University, 1125, Budapest, Hungary; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary; MTA-SE Neuropsychopharmacology Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary; Department of Pharmacodynamics, Semmelweis University, Hungary Department of Psychiatry, No. III, National Institute for Psychiatry and Neurology, Budapest, Hungary; Laboratory of Neurochemistry and Experimental Medicine, National Institute for Psychiatry and Neurology, Budapest, Hungary Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest E-mail: gonda.xenia@med.semmelweis-univ.hu NAP-2-SE New Antidepressant Target Research Group, Semmelweis University, Budapest Pszichiátriai és Pszichoterápiás Klinika, Semmelweis Egyetem, Budapest. NAP3.0 Neuropszichofarmakológia Kutatócsoport, Nemzeti Agykutatási Program, Semmelweis Egyetem, Budapest Department of Psychiatry and Psychotherapy, Kútvölgyi Clinical Center, Semmelweis University, Budapest, Hungary; Laboratory of Suicide Prevention and Research, National Institute for Psychiatry and Addictology, Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary; MTA-SE Neurochemistry and Neuropsychopharmacology Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary;; MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary; Semmelweis University, Hungary; Hungarian Academy of Sciences and Semmelweis University, Hungary; Semmelweis University, Hungary Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary. NAP-3-SE Neuropsychopharmacology Research Group, Semmelweis University, Budapest. Semmelweis Egyetem, Pszichiátriai és Pszichoterápiás Klinika, Budapest, Hungary. rihmer.z@kronet.hu. Department of Clinical and Theoretical Mental Health, Faculty of Medicine, Kútvölgyi Clinical Center, Kútvölgyi út 4., Semmelweis University, 1125 Budapest, Hungary Department of Psychiatry and Psychotherapy, Kutvolgyi Clinical Centre, Semmelweis University, Budapest, Hungary; MTA-SE Neurochemistry and Neuropsychopharmacology Research Group, Hungarian Academy of Sciences and Semmelweis University, Budapest, Hungary; NAP-2-SE New Antidepressant Target Research Group, Semmelweis University, Budapest, Hungary Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary Department of Clinical and Theoretical Mental Health Kútvölgyi Clinical Center Semmelweis University Budapest Hungary International Centre for Education and Research in Neuropsychiatry, Samara State Medical University, Samara, Russia. Department of Pharmacology and Pharmacotherapy, Semmelweis University, Faculty of Medicine, Budapest, Hungary. kendermagos@yahoo.com MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Hungarian Academy of Sciences, Semmelweis University, Budapest, Hungary; NAP-2-SE New Antidepressant Target Research Group, Hungarian Brain Research Program, Semmelweis University, Budapest, Hungary; Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary Department of Psychiatry and Psychotherapy Semmelweis University Budapest Hungary; MTA‐SE Neuropsychopharmacology and Neurochemistry Research Group of the Hungarian Academy of Sciences and Semmelweis University Budapest Hungary; NAP‐A‐SE New Antidepressant Target Research Group, Semmelweis University Budapest Hungary Department of Clinical and Theoretical Mental Health, Kútvölgyi Clinical Center, Semmelweis University, Kútvölgyi út 4., 1125 Budapest, Hungary Department of Pharmacodynamics, Semmelweis University, Faculty of Medicine, Budapest, Hungary.; Department of Clinical and Theoretical Mental Health, Kutvolgyi Clinical Centre, Semmelweis University, Faculty of Medicine, Budapest, Hungary. Department of Clinical, Theoretical Mental Health and Pharmacodynamics, MTA-SE Neuropsychopharmacology and Neurochemistry Research Group, Laboratory of Suicide Prevention and Research, National Institute for Psychiatry and Addictology, Semmelweis University, Budapest, Hungary Department of Clinical and Theoretical Mental Health, Department of Pharmacodynamics, Semmelweis University, Budapest, Hungary NAP-2-SE Új Antidepresszív Gyógyszercélpont Kutatócsoport, Nemzeti Agykutatási Program,Semmelweis Egyetem, Budapest. Department of Clinical and Theoretical Mental Health, Kútvölgyi Clinical Center Semmelweis University Budapest Hungary; Laboratory of Suicide Prevention and Research National Institute for Psychiatry and Addictology Budapest Hungary; Department of Pharmacology and Pharmacotherapy Semmelweis University; MTA‐SE Neurochemistry Research Group Department of Clinical and Theoretical Mental Health, Semmelweis University, Budapest, Hungary; Department of Pharmacodynamics, Semmelweis University, Budapest, Hungary National Institute for Psychiatry and Neurology, Hungary |
Incoming Links
Total number of triples: 247.